<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">vsp</journal-id><journal-title-group><journal-title xml:lang="ru">Вопросы современной педиатрии</journal-title><trans-title-group xml:lang="en"><trans-title>Current Pediatrics</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1682-5527</issn><issn pub-type="epub">1682-5535</issn><publisher><publisher-name>Издательство «ПедиатрЪ»</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">vsp-878</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>В ПОМОЩЬ  ВРАЧУ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>A DOCTOR’S AID</subject></subj-group></article-categories><title-group><article-title>АКТУАЛЬНОСТЬ ПРИМЕНЕНИЯ НЕСТЕРОИДНЫХ ПРОТИВОВОСПАЛИТЕЛЬНЫХ СРЕДСТВ ДЛЯ ЛЕЧЕНИЯ ЛИХОРАДКИ У ДЕТЕЙ</article-title><trans-title-group xml:lang="en"><trans-title>TOPICALITY OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS IN TREATMENT OF FEVER IN CHILDREN</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мубаракшина</surname><given-names>О.А.</given-names></name><name name-style="western" xml:lang="en"><surname>Mubarakshina</surname><given-names>O.A.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Воронежская государственная медицинская академия им. Н.Н. Бурденко</institution><country>Россия</country></aff><aff xml:lang="en"><institution>N.N. Burdenko Voronezh State Medical Academy</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2010</year></pub-date><pub-date pub-type="epub"><day>14</day><month>09</month><year>2015</year></pub-date><volume>9</volume><issue>2</issue><issue-title>Вопросы современной педиатрии</issue-title><fpage>156</fpage><lpage>160</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Мубаракшина О., 2010</copyright-statement><copyright-year>2010</copyright-year><copyright-holder xml:lang="ru">Мубаракшина О.</copyright-holder><copyright-holder xml:lang="en">Mubarakshina O.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://vsp.spr-journal.ru/jour/article/view/878">https://vsp.spr-journal.ru/jour/article/view/878</self-uri><abstract><p>Нестероидные противовоспалительные препараты широко применяются в педиатрической практике для лечения лихорадки у детей. При выборе средств этой группы для назначения детям особенно важно ориентироваться на высокоэффективные препараты с наименьшим риском возникновения побочных реакций. Этим требованиям в полной мере сегодня отвечают только парацетамол и ибупрофен. Они официально рекомендуются ВОЗ в качестве жаропонижающих средств для использования в педиатрии. В статье рассматриваются преимущества ибупрофена в сравнении с парацетамолом, приводятся данные рандомизированных исследований. Уделено внимание вопросам безопасности при лечении ибупрофеном и возможностям комбинированной терапии ибупрофеном и парацетамолом. </p><p>Ключевые слова: дети, лихорадка, ибупрофен, парацетамол, лечение.(Вопросы современной педиатрии. 2010;9(2):156-160)</p></abstract><trans-abstract xml:lang="en"><p>Nonsteroidal anti-inflammatory drugs are widely used in pediatric practice for the treatment of fever. The choice of the drug from this group must be based on high effectiveness of medication and the lowest risk of adverse events. Only paracetamol and ibuprofen completely fulfill these requirements at the present times. They are officially recommended by WHO for the use as an anti-fever pediatric medication. The article examines advantages of ibuprofen compared to paracetamol on the basis of results of randomized studies. Author describes a safety of ibuprofen and opportunities of combined treatment with ibuprofen and paracetamol.</p><p>Key words: children, fever, ibuprofen, paracetamol, treatment.(Voprosy sovremennoi pediatrii — Current Pediatrics. 2010;9(2):156-160)</p></trans-abstract></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Sidler J., Frey B., Baerlocher K. A double-blind comparison of ibuprofen and paracetamol in juvenile pyrexia. Br. J. Clin. Pract. 1990; 70: 22–25.</mixed-citation><mixed-citation xml:lang="en">Sidler J., Frey B., Baerlocher K. A double-blind comparison of ibuprofen and paracetamol in juvenile pyrexia. Br. J. Clin. Pract. 1990; 70: 22–25.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Walson P., Galletta G., Braden N. et al. Ibuprofen, acetaminophen, and placebo treatment of febrile children. Clin. Pharmacol. Ther. 1989; 46: 9–17.</mixed-citation><mixed-citation xml:lang="en">Walson P., Galletta G., Braden N. et al. Ibuprofen, acetaminophen, and placebo treatment of febrile children. Clin. Pharmacol. Ther. 1989; 46: 9–17.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Bertin L., Pons G., d'Athis P. et al. Randomised, double-blind, multicenter, controlled trial of ibuprofen versus acetaminophen (paracetamol) and placebo for treatment of symptoms of tonsillitis and pharyngitis in children. J. Pediatrics. 1991; 119 (5): 811–814.</mixed-citation><mixed-citation xml:lang="en">Bertin L., Pons G., d'Athis P. et al. Randomised, double-blind, multicenter, controlled trial of ibuprofen versus acetaminophen (paracetamol) and placebo for treatment of symptoms of tonsillitis and pharyngitis in children. J. Pediatrics. 1991; 119 (5): 811–814.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Bertin L., Pons G., d'Athis P. et al. A randomised, double-blind, multicentre controlled trial of ibuprofen versus acetaminophen and placebo for symptoms of acute otitis media in children. Fundam. Clin. Pharmacol. 1996; 10: 387–392.</mixed-citation><mixed-citation xml:lang="en">Bertin L., Pons G., d'Athis P. et al. A randomised, double-blind, multicentre controlled trial of ibuprofen versus acetaminophen and placebo for symptoms of acute otitis media in children. Fundam. Clin. Pharmacol. 1996; 10: 387–392.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Lesko S. The safety of acetaminophen and ibuprofen among children less than two years old. Pediatrics. 1999; 104 (4): 1–5.</mixed-citation><mixed-citation xml:lang="en">Lesko S. The safety of acetaminophen and ibuprofen among children less than two years old. Pediatrics. 1999; 104 (4): 1–5.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Lesko S., Louic C., Vezina R. et al. Asthma morbidity after he short–term use of ibuprofen in children. Pediatrics. 2002; 109 (2):1–4.</mixed-citation><mixed-citation xml:lang="en">Lesko S., Louic C., Vezina R. et al. Asthma morbidity after he short–term use of ibuprofen in children. Pediatrics. 2002; 109 (2):1–4.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Kauffmann R., Sawyer L., Scheinbaum M. Antipyretic efficacy of ibuprofen VS acetaminophen. AJDC. 1992; 146: 622–625.</mixed-citation><mixed-citation xml:lang="en">Kauffmann R., Sawyer L., Scheinbaum M. Antipyretic efficacy of ibuprofen VS acetaminophen. AJDC. 1992; 146: 622–625.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Czaykowski D., Fratarcangelo P., Rosefsky J. Evaluation of the antipyretic efficacy of single dose ibuprofen suspension compared to acetaminophen elixir in febrile children. Pediatric Research. 1994; 35 (4): 829.</mixed-citation><mixed-citation xml:lang="en">Czaykowski D., Fratarcangelo P., Rosefsky J. Evaluation of the antipyretic efficacy of single dose ibuprofen suspension compared to acetaminophen elixir in febrile children. Pediatric Research. 1994; 35 (4): 829.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Lesko S., Mitchell A. Renal function after short term ibuprofen use in infants and children. Pediatrics. 1997; 100: 954–957.</mixed-citation><mixed-citation xml:lang="en">Lesko S., Mitchell A. Renal function after short term ibuprofen use in infants and children. Pediatrics. 1997; 100: 954–957.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Autret E., Breart G., Jonville A. et al. Comparative efficacy and tolerance of ibuprofen syrup and acetaminophen syrup in children with pyrexia associated with infectious diseases and treated with antibiotics. Eur J. Clin. Pharmacol. 1994; 46 (3): 197–201.</mixed-citation><mixed-citation xml:lang="en">Autret E., Breart G., Jonville A. et al. Comparative efficacy and tolerance of ibuprofen syrup and acetaminophen syrup in children with pyrexia associated with infectious diseases and treated with antibiotics. Eur J. Clin. Pharmacol. 1994; 46 (3): 197–201.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Wilson J., Brown R., Kearns G. et al. Single-dose, placebocontrolled comparative study of ibuprofen and acetaminophen antipyresis in children. J. Pediatr. 1991; 119 (5): 803–811.</mixed-citation><mixed-citation xml:lang="en">Wilson J., Brown R., Kearns G. et al. Single-dose, placebocontrolled comparative study of ibuprofen and acetaminophen antipyresis in children. J. Pediatr. 1991; 119 (5): 803–811.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Hay A., Costelloe C., Redmond N. et al. Paracetamol plus ibuprofen for the treatment of fever in children (PITCH): randomised controlled trial. BMJ. 2008; 337: 302.</mixed-citation><mixed-citation xml:lang="en">Hay A., Costelloe C., Redmond N. et al. Paracetamol plus ibuprofen for the treatment of fever in children (PITCH): randomised controlled trial. BMJ. 2008; 337: 302.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
